P. Nigel Leigh

Active 1951–2025

142
Papers
30,454
Citations
96
h-index
140
i10-index

Citations

Citations per year for P. Nigel Leigh1951: 21 citations1972: 1 citations1975: 1 citations1976: 5 citations1977: 1 citations1978: 1 citations1979: 2 citations1980: 1 citations1984: 2 citations1986: 1 citations1989: 2 citations1990: 4 citations1991: 11 citations1992: 20 citations1993: 26 citations1994: 28 citations1995: 52 citations1996: 79 citations1997: 88 citations1998: 103 citations1999: 120 citations2000: 125 citations2001: 110 citations2002: 147 citations2003: 180 citations2004: 171 citations2005: 208 citations2006: 241 citations2007: 224 citations2008: 263 citations2009: 355 citations2010: 448 citations2011: 502 citations2012: 452 citations2013: 437 citations2014: 334 citations2015: 316 citations2016: 347 citations2017: 355 citations2018: 258 citations2019: 824 citations2020: 977 citations2021: 820 citations2022: 616 citations2023: 488 citations2024: 707 citations2025: 297 citations2026: 10 citations1952–1971: no citations, so these years are not shown1973–1974: no citations, so these years are not shown1981–1983: no citations, so these years are not shown1985: no citations, so this year is not shown1987–1988: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,662 citing papers, 23% of this breakdownUnited Kingdom: 1,531 citing papers, 13.2% of this breakdownItaly: 880 citing papers, 7.6% of this breakdownGermany: 753 citing papers, 6.5% of this breakdownCanada: 590 citing papers, 5.1% of this breakdownAustralia: 525 citing papers, 4.5% of this breakdownFrance: 487 citing papers, 4.2% of this breakdownChina: 416 citing papers, 3.6% of this breakdownJapan: 405 citing papers, 3.5% of this breakdownNetherlands: 395 citing papers, 3.4% of this breakdownSpain: 268 citing papers, 2.3% of this breakdownBelgium: 245 citing papers, 2.1% of this breakdown
0%23%Other 21%

Fields

  • Medicine72.4%
  • Biochemistry, Genetics and Molecular Biology12.4%
  • Neuroscience11.2%
  • Psychology1%
  • Health Professions0.6%
  • Pharmacology, Toxicology and Pharmaceutics0.5%
  • Other1.9%

Topics

  • Amyotrophic Lateral Sclerosis Research18.4%
  • Neurogenetic and Muscular Disorders Research8.7%
  • Parkinson's Disease Mechanisms and Treatments7.7%
  • Alzheimer's disease research and treatments4.3%
  • Genetic Neurodegenerative Diseases3.9%
  • Neurological diseases and metabolism2.9%
  • Other54.1%

Coauthors

All papers

Open in search
  1. TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis

    Authors: , , , , , , , , , , , , , , , , , - Science 2008 cited by 2,657

  2. Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6

    Authors: , , , , , , , , , , , , , , , , , , , , , - Science 2009 cited by 2,599

  3. Dose-ranging study of riluzole in amyotrophic lateral sclerosis

    Authors: , , , , , - The Lancet 1996 cited by 1,292

  4. A proposed staging system for amyotrophic lateral sclerosis

    Authors: , , , , , , , , , , - Brain 2012 cited by 462

  5. Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alistair Church, Michele T. M. Hu, John Woodside, Henry Houlden, James B. Rowe, Huw R. Morris - JAMA Neurology 2019 cited by 178

  6. Amyotrophic lateral sclerosis.

    Authors: , - Orphanet Journal of Rare Diseases 1951 cited by 948

  7. Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study

    Authors: , , , , , , , - Neurobiology of Disease 2004 cited by 727

  8. Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Neurology 2014 cited by 425

  9. Genetic determinants of survival in progressive supranuclear palsy: a genome-wide association study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John C. van Swieten, Alex Rajput, Leslie W. Ferguson, Mark Cookson, J. Raphael Gibbs, Cornelis Blauwendraat, Jinhui Ding, Ruth Chia, Bryan J. Traynor, Alexander Pantelyat, Coralie Viollet, Bryan J. Traynor, Olga Pletniková, Juan C. Troncoso, Liana S. Rosenthal, Adam L. Boxer, Gesine Respondek, Thomas Arzberger, Sigrun Roeber, Armin Giese, David J. Burn, Nicola Pavese, Alexander Gerhard, Christopher Kobylecki, P. Nigel Leigh, Alistair Church, Michele T.M. Hu - The Lancet Neurology 2020 cited by 120

  10. NEK1 variants confer susceptibility to amyotrophic lateral sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Frank Baas, Anneke J. van der Kooi, Marianne de Visser, Anneloor L.M.A. ten Asbroek, Peter C. Sapp, Diane McKenna‐Yasek, Meraida Polak, Seneshaw Asress, José Luís Muñoz-Blanco, Tim M. Strom, Thomas Meitinger, Karen Morrison, Giuseppe Lauria, Kelly L. Williams, P. Nigel Leigh, Garth A. Nicholson, Ian P. Blair, Claire S. Leblond, Patrick A. Dion, Guy A. Rouleau, Hardev Pall, Pamela J. Shaw, Martin R. Turner, Kevin Talbot, Franco Taroni, Khrista Boylan, Marka van Blitterswijk, Rosa Rademakers, Jesús Esteban‐Pérez, Alberto García‐Redondo, Phillip Van Damme, Wim Robberecht, Adriano Chiò, Cinzia Gellera, Carsten Drepper, Michael Sendtner, Antonia Ratti, Jonathan D. Glass, Jesús S. Mora, Nazlı Başak, Orla Hardiman, Albert C. Ludolph, Peter M. Andersen, Jochen H. Weishaupt, Robert H. Brown, Ammar Al‐Chalabi, Vincenzo Silani, Christopher E. Shaw, Leonard H. van den Berg, Jan H. Veldink, John E. Landers - Nature Genetics 2016 cited by 294

  11. Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study

    Authors: , , , , , , - The Lancet Neurology 2018 cited by 252

  12. Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Shaun Purcell, Sven Cichon, Markus M. Nöthen, H‐Erich Wichmann, Stefan Schreiber, Sita H. Vermeulen, Lambertus A. Kiemeney, John H. J. Wokke, Simon Cronin, Russell L. McLaughlin, Orla Hardiman, Katsumi Fumoto, R. Jeroen Pasterkamp, Vincent Meininger, Judith Melki, P. Nigel Leigh, Christopher E. Shaw, John E. Landers, Ammar Al‐Chalabi, Robert H. Brown, Wim Robberecht, Peter M. Andersen, Roel A. Ophoff, Leonard H. van den Berg - Nature Genetics 2009 cited by 404

  13. Repeated 5-day cycles of low dose aldesleukin in amyotrophic lateral sclerosis (IMODALS): A phase 2a randomised, double-blind, placebo-controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , - EBioMedicine 2020 cited by 80

  14. Neurofilament light levels predict clinical progression and death in multiple system atrophy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alistair Church, Michele T M Hu, James B. Rowe, P. Nigel Leigh, Luke A. Massey, David J. Burn, Nicola Pavese, Thomas Foltynie, Sofya Pchelina, Nicholas Wood, Amanda Heslegrave, Henrik Zetterberg, Martina Bocchetta, Jonathan D. Rohrer, Marı́a José Martı́, Matthis Synofzik, Huw R. Morris, Wassilios G. Meissner, Henry Houlden - Brain 2022 cited by 73

  15. An estimate of amyotrophic lateral sclerosis heritability using twin data

    Authors: , , , , , , - Journal of Neurology Neurosurgery & Psychiatry 2010 cited by 329

  16. The sex ratio in amyotrophic lateral sclerosis: A population based study

    Authors: , , , , , , , , , , , , , , , , , - Amyotrophic Lateral Sclerosis 2010 cited by 211

  17. Joint genome-wide association study of progressive supranuclear palsy identifies novel susceptibility loci and genetic correlation to neurodegenerative diseases

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Molecular Neurodegeneration 2018 cited by 137

  18. Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis

    Authors: , , , , , , , , , , , , - Amyotrophic Lateral Sclerosis 2009 cited by 539

  19. Neurite orientation and dispersion density imaging (NODDI) detects cortical and corticospinal tract degeneration in ALS

    Authors: , , , , , , , , - Journal of Neurology Neurosurgery & Psychiatry 2018 cited by 101

  20. Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: The NNIPPS Study

    Authors: , , , , , - Brain 2008 cited by 346

  21. Variants of the elongator protein 3 ( ELP3 ) gene are associated with motor neuron degeneration

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Human Molecular Genetics 2008 cited by 291

  22. Estimating clinical stage of amyotrophic lateral sclerosis from the ALS Functional Rating Scale

    Authors: , , , , , , , , , - Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2014 cited by 154

  23. A confirmatory dose-ranging study of riluzole in ALS

    Authors: , , , , , , , - Neurology 1996 cited by 199

  24. Characterizing axonal myelination within the healthy population: a tract-by-tract mapping of effects of age and gender on the fiber g-ratio

    Authors: , , , , , , , - Neurobiology of Aging 2016 cited by 104